Catalyst Pharmaceuticals
Price & Volume
Stats
See more52W Range | $19.05-$26.58 |
Market Cap | $2.8B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $588.9M |
Revenue Growth (YoY) | 7.6% |
Gross Profit (12 Mos) | $489M |
Diluted EPS | $1.68 |
News
See moreYahoo Finance • 24 days ago
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
Yahoo Finance • last month
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Yahoo Finance • 3 months ago
Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move?
Yahoo Finance • 3 months ago
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
About
CEO | Mr. Richard John Daly M.B.A. |
CFO | Mr. Michael W. Kalb CPA |
Address | 355 Alhambra Circle, Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 182 |
